Welcome to MedArena!

Your trusted destination for CME, CPD & Medical Education across the Middle East.

Information

  • Address:MedArena Corporation
  • Call Us:1 (800) 828-2059
  • Email:support [at] medarenaevents.com
Dr. Aydah Al Awadhi

Achievements

—Head of the Medical Oncology Department at Tawam Hospital (SEHA / M42 Healthcare) and Clinical Faculty at UAEU.
—Emirati medical milestone: Reported as the first Emirati woman to join the hematology and oncology fellowship program at MD Anderson Cancer Center.
2022Women in Oncology of the Year Award, 2022: Recognized by the Emirates Oncology Society for her contributions to oncology.

Dr. Aydah Al Awadhi

Consultant Medical Oncologist, Head of Medical Oncology Department & Lead Cancer Clinical Researcher

Tawam Hospital (SEHA / M42 Healthcare) & College of Medicine and Health Sciences, United Arab Emirates University

About

Dr. Aydah Al Awadhi is a premier Emirati consultant medical oncologist, clinical researcher, and cancer control strategist who has played a transformational role in elevating oncological care, cancer screening frameworks, and precision medicine standards across the United Arab Emirates. She earned her Doctor of Medicine (MD) degree with distinguished honors, followed by comprehensive postgraduate residency training in internal medicine. Driven to master the complex cellular and genetic mechanisms of malignant diseases, she completed subspecialty clinical fellowship training in medical oncology and hematology, earning a Master of Science (MSc) and Fellowship with the Royal College of Physicians (FRCP).

Practicing as Head of the Medical Oncology Department at Tawam Hospital—the regional center of excellence for cancer care in Al Ain operated by SEHA and M42 Healthcare—Dr. Al Awadhi directs high-acuity diagnostic and therapeutic pathways for solid tumors. Her specialized clinical scope encompasses breast cancer, gastrointestinal malignancies, lung cancer, gynecological oncology, targeted immunotherapies, and complex multi-modal cancer care protocols tailored to Middle Eastern patient populations.

Throughout her clinical tenure at Tawam Hospital, Dr. Al Awadhi has been a pivotal force in embedding oncology care within the broader national non-communicable disease (NCD) framework. Recognizing that early detection remains the single most effective intervention to reduce cancer-related mortality, she collaborates closely with public health authorities to establish standardized, population-wide screening guidelines for breast, colorectal, and cervical cancers across Abu Dhabi and the wider Emirates.

A major milestone of Dr. Al Awadhi’s clinical leadership has been introducing next-generation sequencing (NGS) and biomarker-driven targeted therapies into routine oncology care. Under her direction, multi-disciplinary tumor boards incorporate comprehensive genomic profiling to match cancer patients with personalized immunotherapies and targeted agents, significantly improving therapeutic response rates while minimizing systemic toxicities.

In addition to her departmental directorship and clinical practice, Dr. Al Awadhi is an active academic educator and clinical assistant professor at United Arab Emirates University (UAEU). She actively trains medical oncology fellows,internal medicine residents, and medical students, directing accredited clinical oncology workshops, tumor board seminars, and evidence-based pharmacotherapy modules. Her teaching philosophy emphasizes integrating translational cancer genetics with compassionate, holistic patient communication.

Dr. Al Awadhi is an exceptionally prolific physician-scientist who has authored numerous peer-reviewed scientific studies, clinical registry reports, and treatment guidelines in high-impact international journals, including The Oncologist,Annals of Oncology, Breast Cancer Research and Treatment, and BMC Cancer. Her research portfolio focuses on characterizing genetic mutations unique to Arab cancer cohorts, evaluating real-world outcomes of immune checkpoint inhibitors, and identifying socio-cultural barriers to cancer screening uptake.

Beyond her hospital and university leadership, Dr. Al Awadhi actively serves on national cancer committees, international advisory boards, and regional oncology research taskforces. She frequently represents the UAE at major global summits—such as the European Society for Medical Oncology (ESMO) and the American Society of Clinical Oncology (ASCO)—advocating for expanded clinical trial infrastructure and equitable access to novel anti-cancer therapeutics across the MENA region.

At the First UAE National Congress on NCDs 2026, Dr. Aydah Al Awadhi stands out as a core scientific keynote presenter, session leader, and oncology policy lead. Uniting oncologists, primary care physicians, health economists, and public health strategists, she provides delegates with essential, evidence-based strategies to optimize cancer screening algorithms, adopt state-of-the-art precision therapies, and strengthen national NCD control frameworks nationwide.

Events & Activities

2nd Saudi Breast Cancer Expert Consensus Conference
Dec 18, 2026
In-Person
Dec 18, 2026
In-Person

2nd Saudi Breast Cancer Expert Consensus Conference

Free

The 2nd Saudi Breast Cancer Expert Consensus Conference brings together leading experts to discuss current evidence and develop practical consensus recommendations for managing early and metastatic breast cancer in Saudi Arabia.

Event Troop

  • 2 Days
  • InterContinental Riyadh
3rd Middle East Cardio-Oncology Congress 2026
Oct 31, 2026
In-Person

3rd Middle East Cardio-Oncology Congress 2026

Middle East Heart Academy (MEHA)

  • CME Credits
  • Le Royal Méridien Abu Dhabi - Sheikh Khalifa Street - Abu Dhabi - United Arab Emirates
Oct 31, 2026
In-Person

3rd Middle East Cardio-Oncology Congress 2026

Free

MECO 2026 is a premier medical conference bringing together international, regional, and local experts in Abu Dhabi to discuss the latest advancements in clinical practice and research.

Middle East Heart Academy (MEHA)

  • 2 Days
  • Le Royal Méridien Abu Dhabi - Sheikh Khalifa Street - Abu Dhabi - United Arab Emirates
First UAE National Congress on NCDs 2026
Sep 22, 2026
In-Person

First UAE National Congress on NCDs 2026

WiredIN Events LLC

  • CME Credits
  • InterContinental, Dubai Festival City, Dubai, UAE
Sep 22, 2026
In-Person

First UAE National Congress on NCDs 2026

Free

The First UAE National Congress on NCDs 2026 is a premier event dedicated to reducing the burden of non-communicable diseases through data-driven strategies and collaborative public health initiatives.

WiredIN Events LLC

  • 3 Days
  • InterContinental, Dubai Festival City, Dubai, UAE
CME Certified Courses
Medical Education Hub
Expert Medical Speakers
AI-Powered Learning
Accredited Certificates
Live Medical Events
Continuous Medical Education
CME Certified Courses
Medical Education Hub
Expert Medical Speakers
AI-Powered Learning
Accredited Certificates
Live Medical Events
Continuous Medical Education
CME Certified Courses
Medical Education Hub
Expert Medical Speakers
AI-Powered Learning
Accredited Certificates
Live Medical Events
Continuous Medical Education